Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of cancer cells. Letrozole may fight breast
cancer by reducing the production of estrogen.
PURPOSE: Phase IV trial to study the effectiveness of letrozole in treating postmenopausal
women who have metastatic breast cancer that has been previously treated with tamoxifen.